Lacaita Pietro G, Senoner Thomas, Bilgeri Valentin, Rauch Stefan, Barbieri Fabian, Kindl Benedikt, Plank Fabian, Dichtl Wolfgang, Deeg Johannes, Widmann Gerlig, Feuchtner Gudrun M
Department of Radiology, Medical University Innsbruck, Innsbruck, Austria.
Department of Anaesthesiology and Intensive Care, Medical University Innsbruck, Innsbruck, Austria.
Eur Radiol. 2025 Apr;35(4):2189-2199. doi: 10.1007/s00330-024-11061-3. Epub 2024 Sep 5.
Novel pericardial adipose tissue imaging biomarkers are currently under investigation for cardiovascular risk stratification. However, a specific compartment of the epicardial adipose tissue (EAT), lipomatous hypertrophy of the interatrial septum (LHIS), is included in the pericardial fat volume (PCFV) quantification software. Our aim was to evaluate LHIS by computed tomography angiography (CTA), to elaborate differences to other pericardial adipose tissue components (EAT) and paracardial adipose tissue (PAT), and to compare CT with [F]FDG-PET.
Of 6983 patients screened who underwent coronary CTA for clinical indications, 190 patients with LHIS were finally included (age 62.8 years ± 9.6, 31.6% females, BMI 28.5 kg/cm ± 4.7) in our retrospective cohort study. CT images were quantified for LHIS, EAT, and PAT density (HU), and total PCFV, with and without LHIS, was calculated. CT was compared with [F]FDG-PET if available.
CT-density of LHIS was higher (- 22.4 HU ± 22.8) than all other pericardial adipose tissue components: EAT right and left (97.4 HU ± 13 and - 95.1 HU ± 13) PAT right and left (- 107.5 HU ± 13.4 and - 106.3 HU ± 14.5) and PCFV density -83.3 HU ± 5.6 (p < 0.001). There was a mild association between LHIS and PAT right (Beta 0.338, p = 0.006, 95% CI: 0.098-577) and PAT left (Beta 0.249, p = 0.030; 95% CI: 0.024-0.474) but not EAT right (p = 0.325) and left (p = 0.351), and not with total PCFV density (p = 0.164). The segmented LHIS volume comprised 3.01% of the total PCFV, and 4.3% (range, 2.16-11.7%) in those with LHIS > 9 mm. [F]FDG-PET: LHIS was tracer uptake positive in 83.3% (37.5%: mild and 45.8%: minimal) of 24 patients.
LHIS is a distinct compartment of PCFV with higher density suggesting brown fat and has no consistent association with EAT, but rather with PAT.
LHIS should be recognized as a distinct compartment of the EAT, when using EAT for cardiovascular risk stratification.
LHIS is currently included in EAT quantification software. LHIS density is relatively high, it is not associated with EAT, and has a high [F]FDG-PET positive rate suggesting brown fat. LHIS is a distinct compartment of the EAT, and it may act differently as an imaging biomarker for cardiovascular risk stratification.
新型心包脂肪组织成像生物标志物目前正在研究用于心血管风险分层。然而,心外膜脂肪组织(EAT)的一个特定区域,即房间隔脂肪肥厚(LHIS),被纳入心包脂肪体积(PCFV)定量软件中。我们的目的是通过计算机断层血管造影(CTA)评估LHIS,阐述其与其他心包脂肪组织成分(EAT)和心包旁脂肪组织(PAT)的差异,并将CT与[F]FDG-PET进行比较。
在6983例因临床指征接受冠状动脉CTA检查的筛查患者中,190例LHIS患者最终纳入我们的回顾性队列研究(年龄62.8岁±9.6,女性占31.6%,BMI 28.5kg/cm±4.7)。对CT图像进行LHIS、EAT和PAT密度(HU)定量,并计算有和无LHIS时的总PCFV。如有[F]FDG-PET数据,则将CT与之进行比较。
LHIS的CT密度(-22.4HU±22.8)高于所有其他心包脂肪组织成分:右侧和左侧EAT(97.4HU±13和-95.1HU±13)、右侧和左侧PAT(-107.5HU±13.4和-106.3HU±14.5)以及PCFV密度-83.3HU±5.6(p<0.001)。LHIS与右侧PAT(β0.338,p=0.006,95%CI:0.098-577)和左侧PAT(β0.249,p=0.030;95%CI:0.024-0.474)有轻度关联,但与右侧EAT(p=0.325)和左侧EAT(p=0.351)以及总PCFV密度(p=0.164)无关联。分割后的LHIS体积占总PCFV的3.01%,在LHIS>9mm的患者中占4.3%(范围2.16-11.7%)。[F]FDG-PET:24例患者中83.3%(37.5%:轻度和45.8%:轻度)的LHIS有示踪剂摄取阳性。
LHIS是PCFV的一个独特区域,密度较高提示棕色脂肪,与EAT无一致关联,而是与PAT有关联。
在将EAT用于心血管风险分层时,LHIS应被视为EAT的一个独特区域。
LHIS目前包含在EAT定量软件中。LHIS密度相对较高,与EAT无关联,[F]FDG-PET阳性率高提示棕色脂肪。LHIS是EAT的一个独特区域,作为心血管风险分层的成像生物标志物可能有不同作用。